Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Han

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Transplantation|August 5, 2000
Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient miceW R Han, Y Zhan, L J Murray-Segal, et al.
Transplantation|October 6, 1997
Idarubicin-anti-CD3: a new immunoconjugate that induces alloantigen-specific tolerance in miceP L Mottram, W R Han, L J Murray-Segal, et al.
Transplant Immunology|January 19, 2000
Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allograftsW R Han, L J Murray-Segal, A Gershenzon, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Transplantation|August 5, 2000
Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient miceW R Han, Y Zhan, L J Murray-Segal, et al.
Transplantation|October 6, 1997
Idarubicin-anti-CD3: a new immunoconjugate that induces alloantigen-specific tolerance in miceP L Mottram, W R Han, L J Murray-Segal, et al.
Transplant Immunology|January 19, 2000
Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allograftsW R Han, L J Murray-Segal, A Gershenzon, et al.
Pageof 2